Participated · Series B · Jun 2026

GigaAI (Jijia Vision) develops world models and embodied intelligence systems, publishing GigaWorld (GigaWorld-0, GigaWorld-Policy, GigaWorld-1) and GigaBrain series models and positioning them as core engines for physical AGI. The company has built Maker H01, a high-degree-of-freedom humanoid robot designed for dexterous operation and mobile interaction, and reports commercial implementation in automotive, 3C, warehousing, and home-service scenarios with a target delivery volume in the thousands this year. In autonomous driving the firm released DriveDreamer and related simulators that have served more than 30 leading automotive OEMs and autonomous driving companies. For content production it is developing the Yisu Engine, integrating ultra-long-duration video generation, a real-time 3D world model framework, and 3D human generation tools. GigaAI reports building an industry-leading data base, projecting over 1 million hours of high-quality visual-action data and more than 10 million hours of pre-training data this year. The company was founded in June 2023 and is led by post-90s Tsinghua-educated founder Huang Guan, whose team has achieved top benchmark results (e.g., WorldArena) against major international institutions.

Participated · Series A · Mar 2026

The supplied article set does not provide operational or financial details about Beijing Lingchu Intelligent Technology Co., Ltd. The only company covered in the materials with substantive fundraising and valuation information is PsiBot, a Chinese robotics AI developer that reached a $1.48 billion valuation after a nearly $100 million round. Because the articles do not include information on Lingchu’s products, metrics, founding year, location, revenue, users, or plans, those details cannot be summarized from the provided sources.

Led · Series A · Dec 2025

Errui Xinyue focuses on the frontier field of exosomes, operating a domestic leading platform that spans high-purity extraction, targeted enrichment, high-precision characterization and clinical application development. Based on this platform, the company offers extraction equipment, diagnostic reagents and raw materials that support both research and clinical use. Notably, it has developed a "blood-plasma neuron exosome α-synuclein" assay that enables early, non-invasive diagnosis of Parkinson’s disease. With fresh capital in hand, the company plans to establish a new R&D and manufacturing base in Hefei to complement its existing northern facility, sharply expanding its R&D and scale-up capacity. Additional priorities include upgrading its extraction/enrichment technology, accelerating clinical trials and regulatory filings for key diagnostic kits, broadening exosome applications to more disease areas, and launching health-management products based on medical-grade exosome extracts. Market education and brand building will also be intensified to enlarge its share across research and industrial channels. The newly raised Series A financing—nearly RMB 100 million—provides the runway for these initiatives; no other operating metrics were disclosed.

Participated · Series A · Dec 2025

EngineAI Robotics is positioned as a head player in embodied-intelligence humanoid robotics, developing humanoid robots aimed at commercial deployment in vertical scenarios. The company plans to scale applications of its humanoid robots across sectors such as traffic management, government services, and public security. Strategic investors from industry and government-linked funds are backing its commercialization push, reflecting confidence in its technology and market potential. The recent Series B values the company at over RMB 10 billion and provides capital to accelerate scenario-based deployment. Existing shareholders participated in the round, indicating continued investor support as the company advances toward wider commercialization.

Led · Series A · Nov 2023

鑫巨半导体 is a supplier of wet‑process equipment for the semiconductor industry, focused on designing,研发 and manufacturing large wet processing tools used in high‑performance integrated circuit and semiconductor packaging substrate production. The company’s core products are large wet processing systems for IC and substrate fabrication. It recently completed a near‑¥100 million Series A financing to support its growth. The financing will be used to industrialize 5–10 micrometer‑level IC substrate production equipment required for advanced packaging. Proceeds will also accelerate domestic advanced‑process equipment R&D, expand the team, and advance market commercialization. The article does not disclose revenues, users, founding year, or location. Xinju (Shenzhen) Semiconductor Technology Co., Ltd. develops high-end IC substrate (IC carrier) production equipment and advanced process technologies, with a technical focus on etch and electroplating. Founded in June 2020 and based in Shenzhen, the company reports nearly six national patents with additional patents pending around etch and plating processes. Its core technical and management team come from international first‑tier firms, and Xinju says it has completed development and internal testing of a 5‑micron line/space process and is working to convert those results into mass‑production equipment. The company plans to offer a series of proprietary lithography process equipment — including dry film development (DDV), flash etch (FET), and dry film stripping (DFS) lines — and to provide process‑enablement services such as etch, plating and cleaning to help customers accelerate manufacturing and ensure yield. Xinju highlights long delivery lead times for substrate equipment and cites rapid domestic demand growth as wafer and chip capacity expands; it projects industry investment in new substrate fabs will exceed RMB 150 billion over the next four years. Financially, the company has completed an angel financing round worth several tens of millions of RMB, with Dongfang Fuhai (SME Development Fund) as the sole disclosed investor.